GM1 Ganglioside
Improves There is now substantial evidence that GM1 ganglioside (I13NeuAc-GgOse,Cer) treatment improves the outcome of a variety of CNS insults when evaluated using in vivo or in vitro models (Ledeen, 1984) . The mechanism(s) involved is unclear, though there is evidence that GM1 inserts into cell membranes (Toffano et al., 1980; Ghidoni et al., 1989) and may prevent Ca*+ influx from reaching toxic concentrations within cells (Vaccarino et al., 1987; Favaron et al., 1988; de Erausquin et al., 1990) and/or may support the activity of endogenous neurotrophic substances (Hakomori et al., 1990) .
MPP+ (1 -methyl-4-phenylpyridinium ion), formed in glial cells by monoamine oxidase B, is the neurotoxic product of MPTP (1 -methyl-4-phenyl-I ,2,3,6-tetrahydropyridine) metabolism in brain (Heikkila et al., 1984a (Heikkila et al., ,b, 1985 Nicklas et al., 1985) . MPP+ selectively concentrates in dopaminergic neurons (Javitch et al., 1985) where it disrupts mitochondrial energy metabolism (Singer et al., 1988) , resulting in neuronal death. MPTP has been used to induce model parkinsonism in animals. We have previously demonstrated that GM1 can facilitate the recovery of dopaminergic neurochemical, morphological, and behavioral markers in rodents treated with MPTP (Hadjiconstantinou et al., 1986 (Hadjiconstantinou et al., , 1989a Hadjiconstantinou and Neff, encephalic cultures were prepared from embryonic day-15 (El5) embryos as described by Friedman and Mytilineou (1987) . Pooled ventral mesencephalic tissues were mechanically dissociated and plated at a density of l-l .5 x lo6 cells in 35 mm plastic dishes that were precoated with poly-D-lysine. The number of viable cells added to a dish was determined from trypan blue exclusion and counting in a hemocytameter chamber. Culture medium consisted of Eagle's minimal essential medium supplemented with glucose, 30 mM; L-glutamine, 2 mM; fetal calf serum, 5%; horse serum, 5%; penicillin, 100 U/ml; and streptomycin, 100 pg/ml. Cultures were incubated at 37°C in an atmosphere of 5% CO, in air with 100% relative humidity. The medium was changed every third day. For morphological studies cells were grown on 22 x 22 mm glass coverslips. The morphological appearance of the cells was followed with a phase-contrast microscope.
Treatments. Initial studies were performed to determine the concentration and duration of exposure to MPP+ that would reduce dopamine (DA) uptake in the cultures by about 50%. Based on these studies a concentration of 3 PM MPP+ was added on the fourth day in culture and removed 24 hr later. At this concentration of MPP+ there were no general toxic effects as evidenced by no detectable change ofdish protein content and the morphological appearance of cells with a phase-contrast microscope.
GM1 ganglioside (generously supplied by Dr. Gino Toffano, FIDIA Research Laboratories) was added on day 5 in culture immediately after removing MPP+ . Concentration-response and time-response studies were performed to establish the effectiveness of GM 1. For most studies we treated the cultures for 7 d (day 12 in culture) with 0.5 PM GM1 unless otherwise indicated. GM 1 had no discernable toxic effects on the cultures and did not alter the protein content of washed cultures. In addition, GM1 had no effect on DA uptake or aromatic L-amino acid decarboxylase (AAAD) activity when added to samples during an assay procedure.
For some studies monoclonal IgM anti-GM 1 antibodies (generously provided by Dr. Norman Latov, Columbia University), diluted 1: 100, or the B subunit of cholera toxin (5 &ml) (List Biological Laboratories, Camnbell. CA). which selectivelv binds to GM1 (Fishman. 1986) . was added to control and MPP+-treated cultures, either alone' or together with GM 1.
The influence of glial cells on the response of the dopaminergic neurons to GM1 was evaluated by treating the cultures with cytosine @-D-arabinofuranoside (Ara-C, Sigma, St Louis, MO), 1.25 PM on day 3 in culture for 24 hr. The cultures were washed on day 4 and MPP+ added for 24 hr as described above. the incubation continued for 15 min. Uptake was terminated by removing the medium and washing the cultures three times with ice-cold PBS solution described previously. 'H-DA was extracted from the cultures by adding two separate 0.5 ml portions of a solution of 0.4 M HClO, and absolute ethanol (3:l v/v) and scraping the dishes with a rubber policeman. The extract was sonicated and centrifuged, and a portion of the supematant was counted for radioactivity. Nonspecific DA uptake was estimated in the presence of 5 PM benztropine. To exclude the possible interference of uptake by serotonergic or noradrenergic neurons fluoxetine, 1 PM, and desipramine, 5 MM, respectively, were included in the incubation medium (Prochiantz et al., 1979) . Protein was estimated by the method of Lowry et al. (195 1) .
DA and DOPAC estimation. DA and DOPAC content in the cultures was established using HPLC with an electrochemical detector. In brief, the medium was removed and the dishes washed with the PBS solution described previously. Then the cells were removed from the dishes with 200 ~1 of HClO,, 0.5 M, containing 0.002% ascorbic acid. The mixture was homogenized and centrifuged, and 100 ~1 of the supematant was injected onto our HPLC system (Cohen et al., 1983) .
AAAD estimation. After washing with the PBS solution, cells were scraped from the dishes and homogenized with 130 ~1 of ice-cold sucrose, 0.25 rw. The homogenate, 30 ~1, was incubated in 400 ~1 of a solution containing sodium phosphate buffer, 50 mM, pH 7.2; L-dopa, 0.5 mM (o-dopa for estimation of blank values); ascorbic acid, 0.17 mrq pyridoxal 5-phosphate, 0.0 1 mM; pargyline, 0.1 mM; 2-mercaptoethanol, 1 mM; and EDTA, 0.1 mM. Incubations were performed at 37°C for 20 min and the reaction was stopped by adding 80 ~1 of ice-cold HClO, 0.5 M, containing 10 pmol of 3,4-dihydroxybenzylamine as an internal standard. The mixture was transferred to a small conical polypropylene test tube containing about 20 mg of alumina, and catechol compounds were extracted and assayed by HPLC with electrochemical detection as described previously (Hadjiconstantinou et al., 1988) . Tyrosine hydroxylase immunohistochemistry.
A method described by Beck et al. (199 1) was used for the immunohistochemical studies. Briefly, cultures were washed with the PBS solution and fixed with formaldehyde, 4%, for 30 min. After washing again they were incubated for 24 hr with a monoclonal mouse anti-tyrosine hydroxylase (TH) antibody (LNC 1, generously provided by Dr. Gregory Kapatos, Wayne State University) diluted 1: 1000 in PBS containing bovine serum albumin, 2%; Triton X-100, 0.2%; sodium azide, 0.02%; and goat serum, 1%. Following washing with PBS, cultures were incubated with goat antimouse IaG+A+M (H+L) diluted 1:lOO (Zvmed, San Francisco, CA) for 2 hry After washing again, cultures were incubated for 2 hr with monoclonal mouse peroxidase-antiperoxidase complex (Zymed) diluted 1:lOO. Peroxidase was visualized by incubation with a solution of 6 7 8 9 10 11 12 13 14 15 Days in Culture diaminobenzidine, 1 mg/ml, and 0.015% hydrogen peroxide in PBS. TH-immunopositive cells were visualized with a Leitz Orthoplan 2 microscope coupled to a Dage MT1 CCD72 camera and projected onto a Sony Trinitron super fine pitch monitor PVN 1343MD. Images of the cultures were made with a Sony video printer UP 3000. The number of TH-immunopositive cells, the number of primary and secondary processes, the length of primary processes, and the soma perimeter were established with a computerized image analysis system. Statistical analysis. Data were evaluated by analysis of variance followed by comparison of group differences with a Newman-Keuls test.
Results
Treating E 15 mesencephalic cultures with the dopaminergic neurotoxin MPP+, 3 FM, for 24 hr on day 4 in culture, decreased all of the dopaminergic markers evaluated by 40-60% (see figures and tables). The loss of dopaminergic markers appears to be rather selective for DA-containing neurons as there was no detectable loss of protein from the cultures and there were no striking changes of cell morphology except for the TH-immunopositive cells.
GM 1 treatment enhanced DA uptake in MPP+-lesioned cultures in a time-and concentration-dependent manner (Figs. 1, 2). The response appeared maximal at a concentration of about 0.5 PM GM 1. Enhanced DA uptake was evident as early as 2 d after adding GM1 to the MPP+-lesioned cultures and reached a maximum about 7 d later. When control mesencephalic cultures were incubated with GM 1, there was a small but significant increase of DA uptake (Figs. 1, 2) when studied 7 d after initiating the treatment, day 12 in culture, but not at other days. The response of the MPP+ -treated cultures to GM 1 was maintained as long as the compound was present in the medium. DA uptake decreased after removing GM 1 to values found for untreated MPP+-lesioned cultures (Fig. 3) .
GM1 did not prevent the MPP+-induced loss of DA uptake activity. When GM 1 was added before or together with MPP+ for 24 hr, there was no protection of DA uptake activity compared with cultures that were treated with MPP+ alone (Table  1) .
GM1 treatment elevated DA content in both control and MPP+-lesioned cultures. Only the lesioned cultures had elevated DOPAC content (Table 2) . We attempted to investigate TH activity in the cultures from the conversion of L-tyrosine to L-dopa with analysis by HPLC (Blank and Pike, 1976) and from the generation of 3H,0 during the conversion of 3H-tyrosine to dopa (Reinhard et al., 1986) but found both to be at the limits of sensitivity using the cultures and therefore inadequate for estimating enzyme activity. AAAD activity, however, was easily assayed in the cultures. Treatment with GM1 increased AAAD activity in control cultures ( Table  2) . Addition of MPP+ decreased AAAD in the cultures and treatment with GM 1 enhanced enzyme activity. culture, MPP+, 3 PM, was added for 24 hr, the cultures were washed, and fresh medium was added for the remainder of the study; pretreatment, GMl, 0.5 PM, was added at plating and was present when MPP+ was added on day 4 for 24 hr; after washing fresh addition-free medium was added for the remainder of the study; cotreatment, on day 4 in culture both MPP+ and GM1 were added for 24 hr and removed, and fresh addition-free medium was added for the remainder of the study. DA uptake was assessed on day 12 in cultures. N = 12. * p < 0.05 compared with culture medium alone or with GM1 treatment. About 1% of the cells in our cultures displayed TH-like immunoreactivity (Table 3) . TH-immunopositive cells appeared to be bipolar or multipolar. Treatment with MPP+ decreased the number of TH-immunopositive cells by about 60% without significantly diminishing the total number of phase-bright cells. After MPP+, there were fewer TH-positive cells. They were smaller and had fewer primary processes or no processes, and the observed processes were shorter (Fig. 4, Table 4 ). Treatment of control cultures with GM1 did not change the number of TH-immunopositive cells (Table 3) , and they appeared similar to untreated control cells (Fig. 4, Table 4 ). Addition of GM1 to the MPP+-treated cultures resulted in a two-to threefold increase of TH-immunopositive cells (Table 3 ) to values found for control cultures, and the cells appeared essentially normal (Fig. 4) . This is evident from quantitative image analysis of soma perimeter, the number of primary and secondary processes, and the length of the primary processes (Table 4) .
To study the specificity of the response of the cultures to GM 1, either antibodies to GM 1 or the B subunit of cholera toxin was added concomitantly with GM1 to control and MPP+-treated cultures and DA uptake assayed. Both treatments reduced DA uptake in control cultures and prevented the augmentation of transporter activity by added GM1 (Table 5 ). Both treatments also prevented the DA uptake augmentation that occurs following treatment of MPP+ -1esioned cultures with GM 1. Neither treatment, however, altered DA uptake in MPP+-lesioned cultures without GMl.
Cultures were treated with Ara-C to reduce the ratio of glial cells to dopaminergic neurons (Table 6) , and then the cultures were evaluated for DA uptake. Ara-C reduced dish protein by about 60%, but DA uptake per dish was relatively unaffected; consequently, there was a rise of DA uptake per milligram of protein. Ara-C treatment had no discernable effect on the response of the cultures to GMl.
Discussion
MPTP administration results in the selective destruction of nigrostriatal dopaminergic neurons in humans and other species and therefore is used to induce experimental parkinsonism in animals. The biochemical, morphological, and behavioral deficits induced by MPTP in vivo can be reversed by administering GM1 ganglioside (Hadjiconstantinou et al., 1986 (Hadjiconstantinou et al., , 1989a Mesencephalic cells were grown on coverslips (22 x 22 mm) and treated as described in Table 2 . On day 12 in culture the cells were fixed and the presence ofTH was evaluated by immunohistochemistry. The number ofcells on acoverslip was estimated by counting phase-bright cells in a superimposed counting frame and corrected for the size of the coverslip. N = 4-6 coverslips. * p < 0.05 compared with Medium. ** p < 0.05 compared with MPP'. ical and morphological criteria. There was about a 40-60% loss of DA uptake, DA and DOPAC content, AAAD activity, and TH-immunopositive cells when surveyed 7 d after MPP+ treatment. This observation is consistent with in vivo (Burns et al., 1983; Heikkila et al., 1984a) and in vitro (Mytilineou et al., 1985; Sanchez-Ramos et al., 1988 ) studies where there is evidence for selective destruction of dopaminergic neurons by MPP+. From an analysis of the TH-containing cells in the cultures, the progression of events appears to be loss of TH-immunopositive processes with shrinkage of the soma and eventual loss of the soma image. Loss of DA uptake activity is consistent with the loss of terminal processes and therefore it can be used as an indirect biochemical index to evaluate nerve terminal status. GM1 added to normal or lesioned cultures increased DA uptake in a concentration-dependent manner. MPP+-lesioned cells show enhanced uptake as early as 2 d after adding GM 1, and uptake enhancement is maintained whereas control cultures show enhanced uptake only on day 12 in culture. With the concentration of DA we used for studying DA uptake, the changes observed probably reflect an increased number of transporter sites. Indeed, Leon et al. (1988) found that GM1 treatment increases the V,,. for DA uptake in embryonic mesencephalic cultures. We found that GM1 was able to enhance AAAD activity as well as DA and DOPAC content in both control and MPP+-treated cultures. Apparently the effect of GM1 on the biochemistry of dopaminergic neurons in culture is broad and not a selective effect on DA uptake. GM1 does not protect dopaminergic neurons in vivo when administered before MPTP (Hadjiconstantinou and Neff, 1988) and it does not protect mesencephalic dopaminergic neurons from destruction by MPP+ in vitro. Our present finding that adding GM1 after a lesion has been initiated facilitates the recovery of all neurochemical parameters evaluated is consistent with the in vivo studies also (Hadjiconstantinou and Neff, 1988) . In vivo early initiation of treatment is required for successful recovery as there appears to be a finite time after the insult when GM1 is effective. Moreover, GM 1 treatment in vivo must be uninterrupted or recovery deteriorates (Hadjiconstantinou and Neff, 1988) . Recovery of dopaminergic parameters also deteriorates in the mesencephalic cultures if GM 1 is withdrawn.
Exogenous GM 1 inserts into cell membranes (Toffano et al., 1980) , and it induces differentiation and neurite outgrowth (Doherty et al., 1985; Skaper and Varon, 1985; Skaper et al., 1985; Mugnai and Culp, 1987) . Antibodies to GM1 or the presence of the B subunit of cholera toxin modifies neurite outgrowth (Schwartz and Spirman, 1982; Spirman et al., 1982; Spoerri et al., 1988; Wu and Ledeen, 199 l) , demonstrating the importance of GM1 for this response. We found that DA uptake activity was decreased in control GM 1 -untreated cultures if antibody to GM1 or the B subunit of cholera toxin was added, implying that DA uptake activity, and perhaps other dopaminergic parameters, is dependent either directly or indirectly on GM 1. The GM1 content of serum is low (Dacremont, 1972) ; thus, the response to antibody or the B subunit of cholera in the control untreated cultures is probably the consequence of their interaction with GM1 generated by the culture. Indeed, embryonic mesencephalic cultures can survive in a defined medium and added GM1 promotes DA uptake activity (Dal Toso et al., 1988) . Both GM1 antibody and the B subunit prevented the GM l-induced increase of DA uptake in control and MPP+-treated cultures, implying that a contaminant in the GM 1 preparation is not responsible for the enhanced dopaminergic parameters.
Treatment with GM1 restored the number of TH-immunopositive cells and their morphology to near normal in cultures lesioned with MPP+ yet had little effect on control cultures not lesioned with MPP+ . This may represent rescue by GM 1 of the MPP+ -injured neurons from eventual destruction. Altematively, it is possible that MPP+ reduces TH protein and thus neuron detectability by immunostaining and GM 1 may upregulate TH expression restoring neuron detectability. This interpretation has been offered to explain the effect of NGF on the return of ChAT-immunopositive neurons following injury to cholinergic neurons (Varon et al., 1990) . The fact that DA uptake does not neurotoxic and/or pro-neurotrophic actions. Neuronal insults are associated with excessive prolonged Ca2+ influx that is detrimental for neuronal survival (Rothman and Olney, 1987) . In glutamate-induced neurotoxicity GM 1 prevents the translocation of protein kinase C in injured neurons and may thereby limit intracellular Ca2+ increases (Vaccarino et al., 1987; Favaron et al., 1988; de Erausquin et al., 1990) thus protecting the neuron from delayed death (Manev et al., 1990) . MPP+ increases glutamate in brain (Carboni et al., 1990) and NMDA receptor antagonists can prevent MPP+ neurotoxicity (Turski et al., 1991) . Pretreatment or cotreatment with GM1 together with MPP+ or MPTP does not appear to prevent the toxic effects on dopaminergic neurons in culture or in vivo. However, early and continuous treatment with GM1 after an MPTP or MPP+ lesion is required for a response. The early administration of GM1 after an insult may rescue neurons from delayed degeneration and death associated with elevated glutamate release. Brain-derived neurotrophic factor (BDNF) has been shown to prevent the MPP+ neurotoxicity in mesencephalic cultures by inducing glutathione synthetase activity (Spina et al., 1992) .
In addition to possible anti-neurotoxic properties, GM 1 may have restorative effects by modulating endogenous neurotrophic factor activity. Gangliosides modulate tyrosine kinase activity of trophic factor receptors, such as epidermal growth factor (Bremer et al., 1986) , insulin growth factor-I, and platelet-derived growth factor (Hakomori et al., 1990) . A tyrosine kinase receptor appears important for BDNF activity (Klein et al., 199 1) . Epidermal growth factor (Hadjiconstantinou et al., 199 1) and BDNF promote recovery of mesencephalic neurons in culture (Hyman et al., 1991) . Trophic factors for dopaminergic neurons are present in brain (Prochiantz et al., 1979 (Prochiantz et al., , 1981 di Porzio et al., 1980) and added GM1 may facilitate their action on the injured neurons by modulating their synthesis, release. and/or recentor characteristics. For examnle. GM 1 has Mesencephalic cultures were treated with Ara-C, 1.25 PM, for 24 hr on day 3 in culture. On day 4 in culture they were washed and MPP+, 3 PM, added for 24 hr. On day 5 in culture GM1 was added, indicated in the table, and maintained for the remainder of the study. DA uptake was assayed on day 12 in culture. Data are presented as the mean -C SEM for three or four dishes. * p < 0.05 compared with control. ** p < 0.05 compared with MPP+.
a synergistic effect with NGF on brain cholinergic neurons (Cuello et al., 1989) . Enhanced DA uptake induced by epidermal growth factor is abolished by prior treatment of cultures with Ara-C, implying that the presence of glial cells is necessary for the response (Knusel et al., 1990) . In contrast, Ara-C treatment did not alter the ability of GM1 to enhance DA uptake in cultures lesioned with MPP+, negating a role for glial cells in this response. Moreover, embryonic mesencephalic neurons in a defined culture medium show enhanced DA uptake when GM1 is included (Leon et al., 1988) .
Based on reports in the literature and our studies with MPTP, neurotrophic peptides, and GM 1, we postulate that the following events occur in the cultures lesioned with MPTP and treated with GMl. MPP+ is transported into the mesencephalic dopaminergic neurons and inhibits mitochondrial energy metabolism and all dependent biochemical events. Phenotypic expression is lost and the neurons begin degenerating. Added GM 1 inserts into membranes, limiting excessive Ca2+ influx and facilitating the action of neurotrophic factors present in the cultures, hence rescuing the cells and stimulating phenotypic expression, regeneration, and repair. Apparently, the rescued dopaminergic neurons are dependent on added GM1 as they lose their ability to take up DA if GM1 is removed. This observation is consistent with in vivo studies where dopaminergic parameters were found to deteriorate in MPTP-lesioned animals if GM 1 treatment was terminated (Hadjiconstantinou and Neff, 1988) .
In conclusion, MPP+ induces selective destruction of dopamine@ neurons in rat embryonic mesencephalic cultures. There is loss of DA and DOPAC, AAAD activity, DA uptake, and TH-immunopositive cells. All of these parameters are partially restored by adding GM 1 ganglioside to the cultures.
